ABSTRACT: Nod1 and Nod2 are proteins involved in innate immune defense. These intracellular surveillance proteins detect bacterial peptidoglycan, although requiring distinct motifs to achieve sensing. Detection through Nod1 and Nod2 initiates proinflammatory signaling via NF-B activation, which is necessary for clearance of infecting pathogens from the host. The peptidoglycan product sensed by Nod1 is a motif characteristic of Gram-negative bacteria plus some Gram-positive bacteria, such as Bacillus and Listeria spp. The specificity of Nod1 to detect this subset of bacteria might represent a selective advantage for the host in certain cases when Gram-negative bacteria represent the main threat, such as in the epithelial cells lining the intestinal mucosa. In contrast, Nod2 has been implicated as a general sensor for both Gram-positive and Gramnegative bacteria since muramyl dipeptide (MDP), which is the minimal motif in all peptidoglycans, is the structure recognized by Nod2. Mutations in Nod2 have been associated with autoinflammatory disease in humans, including Crohn's disease. Interestingly, the most common mutation in Nod2 associated with Crohn's disease results in protein product that no longer detects MDP. Although the implications of these findings are still not fully understood, it appears that lack of bacterial sensing through a loss of interaction between mutant Nod2 and MDP contributes to the pathology of disease. A loss of surveillance activity by Nod2 may result in the inability of local responses in the intestinal mucosa to control bacterial infection, thereby initiating systemic responses and leading to aberrant inflammation.
INTRODUCTION
Eukaryotes use the innate and adaptive immune systems to detect and eliminate pathogens. Immediately following infection, the innate immune system is Present address and address for correspondence: D. J. Philpott, Department of Immunology, University of Toronto, King's College Circle, Toronto, Ontario, Canada MS5 IA8. Voice: 416-978-7527; fax: 416-978-1938. e-mail: dana.philpott@utoronto.ca activated, providing a first line of defense against microbes. 1 Through the sensing of pathogen-associated molecular patterns (PAMPs) by specific patternrecognition molecules (PRMs), the innate immune system detects the presence of pathogens. 1 This sensing of microbial PAMPs by host PRMs leads to the activation of signaling pathways, which initiate a defense response designed to destroy the microbe.
Both plants and animals rely on this system of sensing PAMPs by PRMs. PAMPs include essential cell wall components of bacteria, such as peptidoglycan and lipopolysaccharide (LPS), as well as flagella and bacterial nucleic acid motifs. 2 It has been shown that PAMPs can be recognized by either extracellular or intracellular PRMs. For instance, toll-like receptors (TLRs), which are expressed on the surface of various mammalian cells and in distinct subcellular structures, are instrumental in sensing extracellular PAMPs or those that are internalized into specialized compartments. Recently, members of the NAIP [neuronal apoptosis inhibitory protein], CIITA [MHC class II transcription activator], HET-E [incompatibility locus protein from Podospora anserine] and TP1 [telomerase-associated protein]) NACHT-leucine-rich repeat (LRR) protein family (NLRs), including Nod1 and Nod2, have been shown to detect cytosolic pathogen-associated molecular patterns (PAMPs) and are critical for defense against intracellular bacteria.
2 Recent findings suggest that both "outside-in" signaling, via TLRs, as well as "inside-in" signaling, through NLRs, are important in eukaryote defense mechanisms against microbial infection.
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NOD1 AND NOD2-INTRACELLULAR PEPTIDOGLYCAN SENSORS
Studies with the invasive Gram-negative bacteria, Shigella flexneri, first showed that a sensing system was likely present within epithelial cells. 3 Only invasive bacteria were shown to be able to induce the activation of proinflammatory signaling. Indeed, the presentation of bacterial products to the cytosol of epithelial cells through microinjection is sufficient to activate the NF-B pathway and drive the induction of proinflammatory gene expression. 3 It was later shown that Nod1, a protein of the NLR family and surprisingly similar in domain organization to plant resistance proteins, is implicated in this sensing system. 4 Other invasive Gram-negative bacteria, including enteroinvasive Escherichia coli 5 and Pseudomonas aeruginosa, 6 are capable of interacting with Nod1. Finally, it was demonstrated that not only invasive bacteria can be detected by Nod1. Indeed, Helicobacter pylori (H. pylori), a Gram-negative extracellular pathogen that interacts intimately with its host cell, also activates NF-B through a Nod1-dependent pathway. 7 In this case, H. pylori likely "contaminates" the target cell with Nod1 elicitors transferred via a type IV secretion apparatus, which can be likened to a molecular syringe that the bacteria uses to transfer key virulence factors into the host cell (see FIGURE 1 for scheme of Nod1 activation by infection).
One focus of our group and others in the field was to identify the bacterial ligand that stimulated the Nod proteins. For Nod1, it appeared clear early in our studies that the activating component was from Gram-negative bacteria. Our original studies had shown that Gram-positive extracts were either incapable of activating Nod1 or did so very poorly. Using a candidate approach, we tested a number of potential Nod1 agonists isolated from Gram-negative bacteria, including LPS and lipoproteins. However, it was finally discovered that Gram-negative type peptidoglycan could stimulate the Nod1 pathway very efficiently. 8 Peptidoglycan is a complex structure of carbohydrate chains of ␤ (1-4)-linked, alternating N-acetylglucosamine (G) and N-acetylmuramic acid (M) sugars cross-linked by short peptide bridges between the sugar backbone. What is more or less distinct about peptidoglycan from Gram-negative bacteria is the presence of diaminopimelic acid (DAP) in the third position of the peptide chain; in most Gram-positive bacteria, this amino acid is a lysine.
Since PG is a complex molecule, we then focused on identifying the minimal motifs active toward the Nod proteins. Through HPLC fractionation followed by mass spectrometry we showed that Nod1 detects a single muropeptide, GM-Tri DAP , produced as a peptidoglycan degradation product in Gramnegative bacterial metabolism. 8 The minimal peptidoglycan motif detected by Nod1 has revealed that, out of the GM-Tri DAP muropeptide naturally produced by bacteria, the dipeptide moiety D-Glu-mesoDAP is sufficient to trigger Nod1 activation. 9, 10 Nod2 is a general sensor for both Gram-positive and Gram-negative bacteria since biochemical and functional analyses have identified muramyl dipeptide (MDP), the minimal motif in all peptidoglycans, as the essential structure recognized by Nod2. 11, 12 Further analysis of the peptidoglycan structural requirements allowing sensing by Nod2 have shown that, in addition to MDP, Nod2 can detect Muramyl-Tri Lys but not Muramyl-Tri DAP.
9 Interestingly, the most common mutation in Nod2 associated with Crohn's disease, which is a frame-shift mutation resulting in the truncation of the terminal LRR, 13, 14 results in protein product that no longer detects peptidoglycan. 11, 12 Although the implications of these findings are still not fully understood, it appears that lack of bacterial sensing may contribute to the pathology of this disease, at least in some cases. A loss of surveillance activity by Nod2 may result in the inability of local responses in the intestinal mucosa to control bacterial infection, thereby initiating systemic responses and leading to aberrant inflammation.
SENSING SPECIFICITIES BETWEEN HUMAN AND MURINE NOD1
Our interests were then to examine whether additional NLR proteins were involved in detecting fragments of peptidoglycan. One peptidoglycan fragment in particular, called tracheal cytotoxin or TCT, has been known for years to have proinflammatory potential, 15, 16 and our studies clearly showed that this fragment was detected by neither Nod1 nor Nod2. 9 In general, it was demonstrated that TCT has a limited potential of inducing the secretion of proinflammatory products from human monocyte-derived macrophages. 17 In contrast, TCT is highly active toward murine macrophages, where picomolar amounts induce robust cytokine secretion. Interestingly, the Nod1 ligand, Muramyl-Tri DAP , is a very poor agonist of cytokine secretion in murine cells. Using cells derived from mice deficient in Nod1, we showed that TCT was in fact dependent on Nod1, begging the question that perhaps murine and human Nod1 have distinct ligand specificities. This was shown to be indeed the case since transfection of a murine Nod1 into human cells switched their specificity from MuramylTri DAP to TCT. 17 This difference of peptide specificity likely relies on punctual differences between the primary amino acid sequences of LRR from human and mouse Nod1. 18 Our characterization of distinct muropeptide requirements to achieve peptidoglycan sensing by human Nod1 and murine Nod1 likely has important implications in the study of human pathogens that use mouse models of infection to understand the pathogenesis of disease. Indeed, specific peptidoglycan signatures may render a certain pathogen unable to colonize alternative hosts on account of differences in sensing specificities of the machinery of the host's innate immune system.
BIOLOGICAL EFFECTS OF NOD LIGANDS
As mentioned above, Nod ligands can induce cytokine secretion from human and murine cells. We have recently examined in detail the specific effects of Nod ligands on primary human cells, specifically monocytes and dendritic cells (DCs). The Nod2 ligands, MDP and Muramyl-Tri Lys , are potent inducers of cytokine secretion, including IL-6, TNF, and IL-1␤, but in particular IL-8, in both monocytes and DCs, whereas the Nod1 ligand appears to be less potent. 19 Strikingly, neither Nod ligand can induce the maturation of DCs, as measured by increased expression of CD80, CD86, and MHCII. However, both Nod ligands can synergize with low and ineffective doses of LPS to allow for a robust production of cytokines as well as costimulatory molecules in the case of DCs. 19 These findings suggest that during a bacterial insult, multiple ligands, acting through cell surface TLRs and cytoplasmic Nod proteins, act in synergy to potentiate the innate response and influence the nature and direction of the adaptive immune response.
NOD2 FRAME-SHIFT MUTATION IN CROHN'S DISEASE: A LOSS-OF-FUNCTION MUTATION
As discussed above, the most common mutation in Nod2 associated with Crohn's disease is a frame-shift mutation that results in a truncated molecule lacking the last LRR. In vitro studies have used ectopic expression of this mutant protein to show that it no longer functions to sense the Nod2 ligand, MDP. 11, 12 Importantly, the molecule can still activate the NF-B pathway when overexpressed, demonstrating that the mutated protein nevertheless retains some function. Studies using human cells derived from patients with this mutation corroborate these findings; cells from patients with the frame-shift mutation in Nod2 can no longer respond to MDP. 12, 20, 21 What is important to stress, however, is that cells derived from these patients can still respond to other stimulants; LPS, for example, induces similar levels of IL-1␤ from cells isolated from Nod2 frame-shift mutation patients compared to cells isolated from either healthy controls or Crohn's patients with distinct Nod2 or other mutations. 20, 22 Surprisingly, a recent study from our group in collaboration with Mihai Neata and colleagues showed that cells derived from Nod2 frame-shift mutation patients no longer detect Nod2-or Nod1-activating agonists. 22 These findings therefore suggest that Crohn's disease patients carrying this mutation in Nod2 have overall defects in peptidoglycan sensing. How this influences disease development is the important part of the puzzle that remains to be solved.
NOD2 FUNCTION IN THE MOUSE
As discussed above, there seems to be evidence from human data that supports the idea for a loss-of-function scenario during Crohn's disease. Moreover, studies using Nod2-deficient mice also report a general lack of responsiveness to MDP. 17, 23, 24 Although these animals have normal intestinal physiology, and antigen-presenting cells respond normally to various TLR agonists, higher susceptibility to oral infection with L. monocytogenes is observed. 24 Similar to reduced levels of defensins in the gut of Crohn's patients, 25, 26 Nod2-deficient mice show altered antimicrobial peptide expression.
These data, however, contrast with the clinical picture of Crohn's disease. The disease is associated with high levels of proinflammatory cytokines, which are products of NF-B target genes, and thereby argue against a loss-of-function phenotype. 27 Antibodies against TNF-␣, IL-6, and IL-12 and direct inhibition of NF-B are, at least in part, effective therapies for Crohn's disease, indicating that a dampened NF-B response to bacterial products seems contrary to Crohn's disease susceptibility. 28 To look at this problem in more detail, a recent study described the phenotype of a knockout-knockin mouse with a mutation in Nod2 homologous to the major frame-shift mutation in human Crohn's disease. 29 Although these animals did not show abnormalities of the gastrointestinal tract, and isolated macrophages respond normally to TLR agonists, the release of IL-1 upon MDP or peptidoglycan stimulation was markedly elevated. Furthermore, increased intestinal inflammation in a dextran sodium sulfate model was observed, which was paralleled by enhanced IL-1, IL-6, and Cox-2 expression, and apoptosis of lamina propria macrophages. 29 These surprising gain-of-function findings would give an explanation for the phenotype observed in Crohn's disease, but are in stark contrast to reports discussed above using cells derived from human patients. Thus, future research on the species-specific role of Nod2 is needed to clarify these discrepancies.
CONCLUSIONS
Nod1 and Nod2 have now been defined as representatives of a new family of cytoplasmic pathogen-recognition molecules. These two proteins recognize distinct motifs found in the peptidoglycan of bacteria and initiate defensive responses in the host through the activation of NF-B. What will be interesting in the future will be to define the responses downstream of Nod proteins and to compare these responses to those downstream of the TLRs. In this way, the specificity of responses emanating from these different PRRs can be characterized in order to better understand the individual role of these families of proteins in defense responses against microbial infection.
Why does the host require an intracellular means of pathogen detection in addition to the TLRs? The cytoplasmic detection system mediated by Nods likely plays a key role in host defense in those tissues where TLRs are absent or expressed at low levels. 30, 31 This occurs in epithelial cells that line mucosal surfaces, as, for example, in colonic epithelial cells. Since these cells live in constant contact with the microbial flora, expression of TLRs and/or their cofactors is downregulated, especially on the surface epithelium, in order to avoid stimulation of the cells by PAMPs and aberrant inflammation of these tissues. However, when these cells are infected with invasive pathogens or pathogens that interact intimately with the plasma membrane, PAMPs can be transferred to the intracellular compartment, where they interact with Nod proteins and this then initiates the defense response. Thus, Nod proteins likely function as key sentinel molecules to alter host defenses to microbial aggression and maintain intestinal homeostasis.
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Note Added in Proof
Our group 32 and that of Gabriel Nunez 33 recently described a novel interacting partner of Nod2, called Erbin, which appears to alter Nod2 function. Erbin is a member of the LRR and PDZ domain-containing family of proteins (LAPs) and is important for targeting certain proteins to the basolateral membrane of epithelial cells. The specific interaction of Nod2 with Erbin also appears important for its membrane targeting 33 as well as to regulate NFB activity. 32, 33 Furthermore, infection with S. flexneri altered the interaction of Erbin and Nod2, allowing the transient release of Nod2, which is likely important for its activation. 33 Finally, since the frame-shift mutant of Nod2 that is associated with Crohn's disease could not interact with Erbin, 32, 33 one can speculate that disrupted interaction between these two proteins may contribute to the disregulation of mutant Nod2 and have an impact on disease development.
